Results 191 to 200 of about 20,519,205 (284)
An alternative robust estimator of average treatment effect in causal inference. [PDF]
Liu J, Ma Y, Wang L.
europepmc +1 more source
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source
Pseudo-random Number Generator Influences on Average Treatment Effect Estimates Obtained with Machine Learning. [PDF]
Naimi AI, Yu YH, Bodnar LM.
europepmc +1 more source
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source
AteMeVs: An R package for the estimation of the average treatment effect with measurement error and variable selection for confounders. [PDF]
Chen LP, Yi GY.
europepmc +1 more source
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source
Rank-based Model Average Estimator for Average Treatment Effects
Model averaging emerges as an attractive ensemble technique that strategically synthesizes all available information from potential candidate models to enhance estimation accuracy. Despite of having been widely practiced in various areas in biostatistics and economics, its application to causal inference is rather limited.
Lv, Jing, Li, Jialiang
openaire +1 more source
Estimation of Heterogeneous Treatment Effects on Hazard Rates [PDF]
Consider a setting where a treatment that starts at some point during a spell (e.g. in unemployment) may impact on the hazard rate of the spell duration, and where the impact may be heterogeneous across subjects.
Gaure, Simen +3 more
core
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche +10 more
wiley +1 more source

